Pharmacokinetic Study of ASP1517 With Kremezin®

Clinical trial NCT02693613 · COMPLETED

Trial details

NCT number: NCT02693613
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2016-02-01
Primary completion: 2016-04-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.